Related Experiment Videos
Role of certain virulence factors in a murine model of Staphylococcus aureus arthritis
C G Gemmell1, S C Goutcher, R Reid
1Department of Bacteriology, Medical School, University of Glasgow.
Abstract:
The susceptibility of male Swiss white mice (MF1) to Staphylococcus aureus-induced arthritis was investigated with wild-type strain allelic replacement mutants. Comparison was made with a known mouse arthritogenic strain. The development and severity of arthritis were dependent both on the numbers of live bacteria injected intravenously and also on the mutant used; the ID50 ranged from (5 X 10(6))-(1 x 10(8)) cfu. The results indicate that expression of the genes associated with virulence, including those for protein A and alpha-haemolysin, play a major role in the pathogenesis of staphylococcal septic arthritis. When either virulence component was carried by the S. aureus variant, a greater degree of inflammation, pannus formation and cartilage destruction was detected histologically. Loss of one or more virulence factors lowered the septic arthritis severity score based on clinical and histological parameters.
Insights
Investigating Staphylococcus aureus mutants in mice revealed that virulence factors like protein A and alpha-hemolysin significantly increase arthritis severity. Loss of these factors reduces inflammation and cartilage damage in staphylococcal septic arthritis.
Area of Science:
- Microbiology
- Immunology
- Pathogenesis
Background:
- Staphylococcus aureus is a common cause of septic arthritis.
- Understanding the specific virulence factors contributing to staphylococcal arthritis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of Staphylococcus aureus virulence factors, specifically protein A and alpha-hemolysin, in the pathogenesis of septic arthritis in a mouse model.
- To compare the arthritogenic potential of wild-type and mutant S. aureus strains.
Main Methods:
- Male Swiss white mice (MF1) were intravenously injected with varying doses of wild-type and allelic replacement mutants of Staphylococcus aureus.
- Arthritis development and severity were assessed using clinical and histological parameters.
- Infectious dose 50 (ID50) was determined for different mutants.
Main Results:
- Arthritis development and severity were dose-dependent and varied significantly among the S. aureus mutants.
- Mutants expressing protein A and alpha-hemolysin exhibited increased inflammation, pannus formation, and cartilage destruction.
- The infectious dose 50 (ID50) ranged from 5 x 10^6 to 1 x 10^8 colony-forming units (cfu).
- Loss of key virulence factors resulted in lower septic arthritis severity scores.
Conclusions:
- Protein A and alpha-hemolysin are major contributors to the pathogenesis of Staphylococcus aureus-induced septic arthritis.
- Modulating these virulence factors can significantly impact disease severity, offering potential therapeutic targets.